InvestorsHub Logo
Followers 71
Posts 7941
Boards Moderated 0
Alias Born 01/29/2015

Re: tcm55 post# 15979

Wednesday, 05/25/2022 2:47:47 PM

Wednesday, May 25, 2022 2:47:47 PM

Post# of 16697
Just so you know...the FDA will approve of someone's grandma 's recipe for turkey gravy to conduct a study on how fat mice can get by licking it up.

Meanwhile, do you remember Christopher Moreau (CEO) telling the market back in Q4 how EXCITING it was going to be for Algernon Pharmaceuticals in 2022?

It would appear that dredging up old stories suggests one isn't very excited at all. It's gotta be killing Moreau to not be in front of a lens spinning and spewing more stories.

The following web address + email address would be money well spent, but like everything else Moreau does, it'll likely be something management/shareholders will learn the hard way:

https://algernonpharma.com/

After all, all the so-called marketing has been Algernon's biggest quarterly expense. Anybody think they've gotten their monies worth to date?

Expect more of the same...

M$

P.S Anyone seen or heard from the BioPub Boys lately? I'm not a subscriber so I'm curious to know if they're still receiving private updates by the CEO & Company? Maybe it doesn't matter since Dr. KSS remains an insiders advisor (conflict of interest) @ Algernon Pharmaceuticals Inc.